Need help? +44 (0) 7457 418426

MEDICINE DETAILS

Tezspire

Active ingredient: Tezepelumab Ekko

Neutral reference profile for an independent medicine-access consultancy enquiry about Tezspire (Tezepelumab Ekko). No medicine is offered for sale.

NEXT STEP

Choose the strength and pack

✓ If you are unsure, choose “I do not know”.

These options are not medical advice, a dosing recommendation, stock confirmation or a sale offer.

ABOUT THIS MEDICINE

What is Tezspire used for?

Tezspire (tezepelumab-ekko) is a thymic stromal lymphopoietin (TSLP) blocker indicated as an add-on maintenance therapy for severe asthma in adults and pediatric patients aged 12 years and older.

It is not indicated for the relief of acute bronchospasm or status asthmaticus, but it can help prevent severe asthma attacks (exacerbations) and can improve breathing.

It is available in vial form or as a syringe, each containing 110 mg/mL tezepelumab-ekko.

This information is general and is not medical advice. Talk to your doctor or pharmacist about any treatment decision.

RECORDED PRODUCT PROFILE

Tezspire identity, dosage form and pack information.

The details below are assembled from current catalogue records. They must still be checked against the prescription, medicine box and an official regulatory record.

Brand recordTezspire
Active ingredientTezepelumab Ekko
Dosage formsolution for injection
Recorded options4
Directory areaPulmonology
Catalogue synchronised

Recorded strength and pack options

Each row is shown only to help identify the product; it is not stock confirmation or a sale offer.

  1. 210 mg · 1 pen Catalogue organisation: AstraZeneca GmbH GB Spezialvertrieb
  2. 210 mg · 1 pre-filled syringe Catalogue organisation: AstraZeneca GmbH GB Spezialvertrieb
  3. 210 mg · 3 pens Catalogue organisation: AstraZeneca GmbH GB Spezialvertrieb
  4. 210 mg · 3 pre-filled syringes Catalogue organisation: AstraZeneca GmbH GB Spezialvertrieb

OFFICIAL SOURCES

Check the Tezspire record at an official source.

Search for “Tezspire” or “Tezepelumab Ekko”. Finding a product in one source does not by itself confirm stock, authorisation in a particular country or suitability for a patient.

SERVICE BOUNDARY

Information checking and independent enquiry support for Tezspire.

OrphanDrug helps organise the product identity and recorded strength and pack details for an enquiry. It does not sell, take payment for, prescribe, import, dispense or deliver medicines.

Clinical decision: Only a qualified healthcare professional who has assessed the patient can decide whether a product, form or dose is appropriate.

CLEAR ANSWERS

Frequently asked questions about Tezspire

01What is Tezspire?

This directory record associates the brand name Tezspire with the active ingredient Tezepelumab Ekko. The brand and ingredient are shown for product identification only, not as treatment or dosing advice.

02Which Tezspire strengths and packs are recorded?

The catalogue currently shows: 210 mg · 1 pen; 210 mg · 1 pre-filled syringe; 210 mg · 3 pens; 210 mg · 3 pre-filled syringes. Check the complete strength, dosage form and pack description against the prescription and medicine box.

03Who manufactures Tezspire?

Catalogue records currently name: AstraZeneca GmbH GB Spezialvertrieb. This field may identify a manufacturer, marketing-authorisation holder, marketing company or supplier; confirm the exact role on the pack leaflet and official regulatory record.

04Do the listed options confirm stock or access?

No. A catalogue record does not confirm current stock, authorisation in a particular country, clinical suitability, import permission or access.

05What affects a possible estimated medicine cost for Tezspire?

A possible cost depends on the exact strength, dosage form, pack, quantity, destination and regulatory jurisdiction. Any amount provided after an enquiry is an indicative medicine-cost estimate only, not a selling price for Tezspire, payment request, stock guarantee or binding offer.

06Can I buy Tezspire from this website?

No. This website does not sell, take payment for, prescribe, import, dispense or deliver medicines. The form creates an independent consultancy enquiry only.